» Articles » PMID: 32660089

Super Secondary Structures of Proteins with Post-Translational Modifications in Colon Cancer

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Jul 15
PMID 32660089
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

New advances in protein post-translational modifications (PTMs) have revealed a complex layer of regulatory mechanisms through which PTMs control cell signaling and metabolic pathways, contributing to the diverse metabolic phenotypes found in cancer. Using conformational templates and the three-dimensional (3D) environment investigation of proteins in patients with colorectal cancer, it was demonstrated that most PTMs (phosphorylation, acetylation, and ubiquitination) are localized in the supersecondary structures (helical pairs). We showed that such helical pairs are represented on the outer surface of protein molecules and characterized by a largely accessible area for the surrounding solvent. Most promising and meaningful modifications were observed on the surface of vitamin D-binding protein (VDBP), complement C4-A (CO4A), X-ray repair cross-complementing protein 6 (XRCC6), Plasma protease C1 inhibitor (IC1), and albumin (ALBU), which are related to colorectal cancer developing. Based on the presented data, we propose the impact of the observed modifications in immune response, inflammatory reaction, regulation of cell migration, and promotion of tumor growth. Here, we suggest a computational approach in which high-throughput analysis for identification and characterization of PTM signature, associated with cancer metabolic reprograming, can be improved to prognostic value and bring a new strategy to the targeted therapy.

Citing Articles

Mass Spectrometry Strategies for -Glycoproteomics.

Helms A, Brodbelt J Cells. 2024; 13(5.

PMID: 38474358 PMC: 10930906. DOI: 10.3390/cells13050394.


The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.

Battle S, Gogonea V, Willard B, Wang Z, Fu X, Huang Y J Biol Chem. 2022; 298(4):101832.

PMID: 35304099 PMC: 9010765. DOI: 10.1016/j.jbc.2022.101832.


Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.

Wang Y, Zhou S, Wang D, Wei T, Zhu J, Li Z Front Endocrinol (Lausanne). 2021; 12:737638.

PMID: 34803909 PMC: 8603925. DOI: 10.3389/fendo.2021.737638.


Current Approaches in Supersecondary Structures Investigation.

Rudnev V, Kulikova L, Nikolsky K, Malsagova K, Kopylov A, Kaysheva A Int J Mol Sci. 2021; 22(21).

PMID: 34769310 PMC: 8584461. DOI: 10.3390/ijms222111879.


Changes in Protein Structural Motifs upon Post-Translational Modification in Kidney Cancer.

Tikhonov D, Kulikova L, Rudnev V, Kopylov A, Taldaev A, Stepanov A Diagnostics (Basel). 2021; 11(10).

PMID: 34679534 PMC: 8534394. DOI: 10.3390/diagnostics11101836.


References
1.
Read J, Choy S, Beale P, Clarke S . Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006; 55(1):78-85. DOI: 10.1207/s15327914nc5501_10. View

2.
Lexa K, Dolghih E, Jacobson M . A structure-based model for predicting serum albumin binding. PLoS One. 2014; 9(4):e93323. PMC: 3972100. DOI: 10.1371/journal.pone.0093323. View

3.
Hitosugi T, Chen J . Post-translational modifications and the Warburg effect. Oncogene. 2013; 33(34):4279-85. DOI: 10.1038/onc.2013.406. View

4.
Sutendra G, Dromparis P, Kinnaird A, Stenson T, Haromy A, Parker J . Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer. Oncogene. 2012; 32(13):1638-50. DOI: 10.1038/onc.2012.198. View

5.
Parodi A, Miao J, Soond S, Rudzinska M, Zamyatnin Jr A . Albumin Nanovectors in Cancer Therapy and Imaging. Biomolecules. 2019; 9(6). PMC: 6627831. DOI: 10.3390/biom9060218. View